Full Text View
Tabular View
No Study Results Posted
Related Studies
Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome (Surfactant 1)
This study has been completed.
Study NCT01203358   Information provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

First Received on September 15, 2010.   Last Updated on January 9, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Infant, Newborn
Infant, Low Birth Weight
Infant, Small for Gestational Age
Infant, Premature
Bronchopulmonary Dysplasia
Additional conditions recognized in this trial
Birth Weight
Respiratory Distress Syndrome, Adult
Respiratory Distress Syndrome, Newborn
More general conditions related to this trial
Body Weight
Infant, Newborn, Diseases
Infant, Premature, Diseases
Lung Diseases
Lung Injury
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms
Ventilator-Induced Lung Injury
Interventions listed in this trial
Exosurf
Survanta
Additional drug interventions recognized in this trial
Beractant
Pulmonary Surfactants
More general drug interventions related to this trial
Pharmacologic Actions
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services